Charles Schwab Investment Management »

Akero Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $13M 518k 25.26
2023-12-31 $9.9M 426k 23.35
2023-09-30 $21M 419k 50.58
2023-06-30 $14M 295k 46.69
2023-03-31 $9.1M 238k 38.26
2022-12-31 $13M 237k 54.80
2022-09-30 $7.3M 213k 34.05
2022-06-30 $1.6M 165k 9.45
2022-03-31 $2.5M 174k 14.19
2021-12-31 $3.7M 174k 21.15
2021-09-30 $3.7M 165k 22.35
2021-06-30 $3.4M 139k 24.81
2021-03-31 $3.2M 111k 29.02
2020-12-31 $2.8M 108k 25.80
2020-09-30 $3.3M 108k 30.79
2020-06-30 $1.3M 51k 24.93
2020-03-31 $940k 44k 21.21
2019-12-31 $804k 36k 22.20
2019-09-30 $735k 32k 22.76